Oxford Pharmascience Group Plc Company Profile (LON:OXP)

About Oxford Pharmascience Group Plc

Oxford Pharmascience Group Plc logoOxford Pharmascience Group plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in re-developing medicines. The Company engages in research and development activities based around its core technology platforms and focuses on commercializing the related products to pharmaceutical organizations. The Company's pipeline is focused on pain relief and cardiovascular disease indications. The Company's pipeline includes Ibuprofen, Naproxen, Diclofenac and Aspirin. Its nonsteroidal anti-inflammatory drug (NSAID) clinical development program involves re-developing NSAIDs to make them milder in the gastrointestinal (GI) tract and mask the typical NSAID taste/burn. The Company's SafeStat clinical development program includes developing statins platform. The Company's OXPzero Technology releases the drug in its molecular ionized form, reducing localized concentration.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: OXP
  • CUSIP:
Key Metrics:
  • Previous Close: $0.03
  • 50 Day Moving Average: $2.90
  • 200 Day Moving Average: $4.62
  • 52-Week Range: £12,056,610 - GBX 2.38
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $30.38M
  • Outstanding Shares: 1,205,661,000
Additional Links:

Analyst Ratings

Consensus Ratings for Oxford Pharmascience Group Plc (LON:OXP) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Oxford Pharmascience Group Plc (LON:OXP)
Show:
DateFirmActionRatingPrice TargetDetails
7/21/2016Beaufort SecuritiesDowngradeHoldView Rating Details
1/25/2016N+1 SingerReiterated RatingCorporateView Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Oxford Pharmascience Group Plc (LON:OXP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Oxford Pharmascience Group Plc (LON:OXP)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Oxford Pharmascience Group Plc (LON:OXP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Oxford Pharmascience Group Plc (LON:OXP)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Oxford Pharmascience Group Plc (LON:OXP)
DateHeadline
News IconOxford Pharmascience Group Plc Pipeline Review, Market Growth, Trends and Clinical trial 2016 – 2020 (LON:OXP)
www.medgadget.com - September 14 at 6:47 PM
morningstar.co.uk logoOxford Pharmascience Interim Loss Narrows As New Products Near Launch (LON:OXP)
www.morningstar.co.uk - September 8 at 10:30 AM
publicnow.com logoInterim results for the 6 months to 30 June 2016 (LON:OXP)
www.publicnow.com - September 7 at 10:11 AM
biz.yahoo.com logoHalf Year 2016 Oxford Pharmascience Group PLC Earnings Release - Time Not Supplied (LON:OXP)
biz.yahoo.com - September 7 at 10:11 AM
4-traders.com logoOxford Pharmascience : Seeks Partner For Bitter Pill Masking Platform (LON:OXP)
www.4-traders.com - July 21 at 7:02 PM
iii.co.uk logoOxford Pharmascience Group ( OXP ) (LON:OXP)
www.iii.co.uk - July 21 at 7:02 PM
publicnow.com logoShares Magazine Investor Evening Presentation (LON:OXP)
www.publicnow.com - May 20 at 3:33 AM
publicnow.com logoOXP to exhibit at the Master Investor Show 2016 (LON:OXP)
www.publicnow.com - April 22 at 7:25 AM
publicnow.com logoPositive Regulatory Advice from MHRA (LON:OXP)
www.publicnow.com - April 19 at 2:05 AM
biz.yahoo.com logoFull Year 2015 Oxford Pharmascience Group PLC Earnings Release - Time Not Supplied (LON:OXP)
biz.yahoo.com - March 4 at 7:07 AM
4-traders.com logoOxford Pharmascience : Adds Former Reckitt Director Sharma To Board (LON:OXP)
www.4-traders.com - February 26 at 2:43 PM
bloomberg.com logoOxford Pharmascience Climbs on Search for Marketing Partner (LON:OXP)
www.bloomberg.com - January 25 at 4:40 AM
noodls.com logoNaproxen Progresses into Proof of Concept Trials (LON:OXP)
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoNSAIDs Programme & Year End Financial Review (LON:OXP)
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoSuccessful Pilot Clinical Study (LON:OXP)
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoPK Results for OXPzero Naproxen vs. Naprosyn (LON:OXP)
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoIbuprofen progressing to proof of concept trial (LON:OXP)
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoInitiation of Pilot Clinical Study for Naproxen (LON:OXP)
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoProposed Placing (LON:OXP)
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoGrant of Share Options (LON:OXP)
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoPosting of Circular and Notice of GM (LON:OXP)
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoResult of GM (LON:OXP)
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoInitiation of Pilot Clinical Study (LON:OXP)
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoInitiation of Pilot Clinical Study for Ibuprofen (LON:OXP)
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoResults from Pilot Clinical Study of OXP500 (LON:OXP)
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoPreliminary PK Data & Initiation of Further Study (LON:OXP)
us.rd.yahoo.com - January 14 at 11:02 AM

Social


Last Updated on 9/26/2016 by MarketBeat.com Staff